Faculty

Travis E. Grotz, M.D.

Clinical Studies

A Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP trial Rochester, Minn.
The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low volume peritoneal metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy.
Molecular Diagnosis of Occult Peritoneal Metastasis from Gastric Cancer (MOPMEG) Rochester, Minn.
The purpose of this study is to establish a clinical useful gene expression panel for detecting and predicting peritoneal relapse and survival to address the unmet clinical need for a simple and accurate staging of the peritoneum in gastric cancer.

A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy for Patients with Pancreatic Cancer and Peritoneal Metastasis Rochester, Minn.
The primary purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with pancreatic adenocarcinoma with limited low volume peritoneal metastasis or positive peritoneal cytology undergoing hyperthermic intraperitoneal chemotherapy.
Prospective Database of All Patients with Peritoneal Surface Malignancies Treated at Mayo Clinic Rochester, Minn.
The purpose of this study is to:
1. Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester.
2. Design and implement quality improvement projects utilizing this database
3. Design and implement outcomes research using this prospective database
4. Design and implement quality of life studies using this prospective database